Korean J Hepatobiliary Pancreat Surg.  2006 Sep;10(3):47-50.

A Hepatic Epithelioid Hemangioendothelioma Treated by Living Donor Liver Transplantation

Affiliations
  • 1Center for Liver Cancer, National Cancer Center, Korea. spark@ncc.re.kr
  • 2Department of Surgery, Busan St. Mary's Medical Center, Korea.
  • 3Department of Surgery, Seoul National University College of Medicine, Korea.

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare a lowgrade malignant tumor of endothelial origin. The natural history of this tumor is unpredictable and it is difficult to differentiate from cholangiocarcinoma or metastatic liver tumor on imaging study. A case of HEHE treated by living donor liver transplantation (LDLT) is presented. A 52-year-old man was admitted because of multiple bilobar liver masses. The histological appearances of the preoperative biopsy showed positive immunostaining for factor VIII and CD34 antigens. So it was dagrored as HEHE The tumor was unresectable because of multiple involvement of both lobes of the liver. The tumor was enlarged after 3months, which prompted the decision to perform LDLT. The right liver of the donor was transplanted to the recipient. The intraoperative & postoperative courses were uneventful. At the time of writing, the patient had survived for 13 months without any complications.

Keyword

Hepatic Epithelioid Hemangioendothelioma; Living Donor Liver Transplantation

MeSH Terms

Antigens, CD34
Biopsy
Cholangiocarcinoma
Factor VIII
Hemangioendothelioma, Epithelioid*
Humans
Liver Transplantation*
Liver*
Living Donors*
Middle Aged
Natural History
Tissue Donors
Writing
Antigens, CD34
Factor VIII
Full Text Links
  • KJHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr